The Pen Needles market size is USD 1.6 Bn in 2026.
The Pen Needles market is projected to grow at a CAGR of 9% by 2033.
The Pen Needles market growth drivers include rising prevalence of diabetes, increasing geriatric population, and demand for efficient drug delivery systems.
North America is a dominating region for Pen Needles market.
Novo Nordisk A/S, UltiMed Inc., Becton Dickinson and Company, Ypsomed Holding AG, and Roche Diabetes Care are some leading industry players in the Pen Needles market.